Two patients with chronic lymphocytic leukemia (CLL) can face very different futures. One may live for decades without ...
B lymphocytes constitute a central arm of adaptive immunity, mediating pathogen neutralisation through high‐affinity antibodies while also shaping immune homeostasis via regulatory functions. Naive B ...
Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is a standard treatment for relapsed or refractory B-cell non-Hodgkin lymphomas. Long-term results and curative potential remain uncertain. We ...
Outcomes of salvage radiotherapy in relapsed/refractory large B-cell lymphoma patients following CAR T-cell therapy failure.
The study, "A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans,” was published in Immunity. “Our study ...
Two patients with chronic lymphocytic leukemia (CLL) can face very different futures. One may live for decades without ...
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP The pathobiology of chronic ...
Please provide your email address to receive an email when new articles are posted on . Learning from 2 decades of off-label rituximab use in systemic lupus erythematosus may point the way toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results